We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sepal’s First Inspection Results in Warning Over Procedures
Sepal’s First Inspection Results in Warning Over Procedures
November 19, 2010
A Boston-based distributor of reproductive devices and diagnostics failed to establish a number of written procedures and does not have a PMA or 510(k) for some of its products, according to an FDA warning letter.